Regenicin, Inc. (RGIN) Financial Statements

Regenicin, Inc. (RGIN) files with the U.S. Securities and Exchange Commission under CIK 0001412659. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2022

Total Assets: $15.49 thousand

Fiscal year ended Sep 30, 2022. Latest periodic SEC filing: May 15, 2023. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for RGIN in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History